These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24478270)

  • 41. Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
    Rodriguez AE; Vigo CF; Delacasa A; Mieres J; Fernandez-Pereira C; Bernardi V; Bettinoti M; Rodriguez-Granillo AM; Rodriguez-Granillo G; Santaera O; Curotto V; Rubilar B; Tronge J; Palacios IF; Antoniucci D;
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):335-42. PubMed ID: 20824769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.
    Koizumi T; Fitzgerald PJ; Honda Y; Ellis SG; Kent K; Martin SL; Brown CL; Masud AR; Patterson JB; Greenberg J; Friedman M; Uchida T; Stone GW
    Cardiovasc Revasc Med; 2010; 11(3):140-8. PubMed ID: 20599163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late target lesion revascularization after implantation of sirolimus-eluting stent.
    Hong MK; Mintz GS; Lee CW; Park DW; Lee SW; Kim YH; Jung IH; Kim SH; Cheong SS; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):299-303. PubMed ID: 17985380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions.
    Verheye S; Ramcharitar S; Grube E; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Spaargaren R; Serruys PW; García-García HM; van Geuns RJ
    EuroIntervention; 2011 Sep; 7(5):580-7. PubMed ID: 21930462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How should I treat a patient to remove a fractured jailed side branch wire?
    Owens CG; Spence MS
    EuroIntervention; 2011 Aug; 7(4):520-7. PubMed ID: 21764672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
    Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-eluting stent implantation in bifurcated lesions with balloon-crushing technique and 6 fr guiding catheter: immediate and mid-term results.
    Lozano I; Avanzas P; Lee DH; Lasa G; Rondán J; Moris C
    J Invasive Cardiol; 2007 Jan; 19(1):27-31. PubMed ID: 17297182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optical coherence tomography assessment of a coronary bare cobalt chromium stent deformed by the removal of an entrapped "jailed" guidewire.
    Agostoni P; Van Belle E; Stella PR
    J Invasive Cardiol; 2010 Sep; 22(9):453-5. PubMed ID: 20814056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study.
    Salvatella N; Morice MC; Darremont O; Tafflet M; Garot P; Leymarie JL; Chevalier B; Lefèvre T; Louvard Y; Boudou N; Dumonteil N; Carrié D
    EuroIntervention; 2011 Oct; 7(6):689-96. PubMed ID: 21986327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
    Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
    Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Techniques, strategies, and dogmas in bifurcation stenting and side branch protection: some food for thought.
    Tan WA
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):757-8. PubMed ID: 25322714
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of endothelial progenitor capture cell stent during percutaneous treatment of coronary bifurcations: a prospective angiographic registry.
    Rognoni A; Secco GG; Lupi A; Santagostino M; Sansa M; Bongo AS; Rognoni G
    Crit Pathw Cardiol; 2011 Dec; 10(4):189-92. PubMed ID: 22089276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
    Abizaid A; Popma JJ; Tanajura LF; Hattori K; Solberg B; Larracas C; Feres F; Costa Jde R; Schwartz LB
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):914-9. PubMed ID: 18044791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, prospective, two-center comparison of sirolimus-eluting stent and zotarolimus-eluting stent in acute ST-elevation myocardial infarction: the SEZE trial.
    Chung WY; Kang J; Cho YS; Park HJ; Yang HM; Seo JB; Suh JW; Kim KI; Youn TJ; Kim SH; Chae IH; Zo JH; Kim MA; Choi DJ
    Chin Med J (Engl); 2012 Oct; 125(19):3373-81. PubMed ID: 23044291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents.
    Billinger M; Räber L; Hitz S; Stefanini GG; Pilgrim T; Stettler C; Zanchin T; Pulver C; Pfäffli N; Eberli F; Meier B; Kalesan B; Jüni P; Windecker S
    Am Heart J; 2012 May; 163(5):876-886.e2. PubMed ID: 22607867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. True coronary bifurcation lesions: meta-analysis and review of literature.
    Athappan G; Ponniah T; Jeyaseelan L
    J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):103-10. PubMed ID: 19952947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Choice of stenting strategy in true coronary artery bifurcation lesions.
    Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
    Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.